Zalcitabine
Brand names
Usage
To treat HIV (human immunodeficiency
virus) infection, usually in combination with other antiretroviral
medicaments. While
not a cure, such medications may suppress replication of the virus and delay the
progression of the disease.
How it works
Zalcitabine (ddC) interferes
with the activity of enzymes
needed for the replication
of DNA in viral cells, thus
preventing the virus from
reproducing.
Side effects
- Serious
- Burning, tingling,
pain, or
numbness in hands or feet,
fever,
muscle pain,
joint pain, skin
rash, ulcers in mouth
and throat, nausea, vomiting,
sore throat, yellow
discoloration of eyes or skin.
- Common
- No common side effects have been reported.
- Less common
- Diarrhea,
headache.
Possible interactions
- Other medicaments:
Zalcitabine may increase the effects of:
- zidovudine (Retrovir) and enhance its antiviral effect against HIV-serious
patient reactions to either of these medicines should be reported to the FDA.
Zalcitabine taken concurrently with:
- antacids (various) may blunt zalcitabine effectiveness.
- cimetidine (Tagamet) may result in toxic zalcitabine levels.
- didanosine (Videx) may result in additive neurotoxicity.
- metoclopramide (Reglan) may result in lowered
blood levels of zalcitabine
and reduced therapeutic benefits.
- other medicaments that cause neurotoxicity or pancreatitis may lead to
addictive toxicity-these combinations are best avoided.
- pentamidine (Nebupent) may lead to increased risk of
pancreatitis.
- probenecid (Benemid) may lead to zalcitabine toxicity.
- Herbal medicines or minerals:
- Some patients use Echinacea to attempt to boost
their immune systems. Use of
Echinacea is not recommended
in people with damaged immune systems. This herb may also actually
weaken any immune system if it is used too often or for too long a time.
- Discontinuation:
- Do not stop this medicament without your physician's knowledge and
guidance.
Comments
|